Residency program director UPMC
Radiation Oncology
Sushil Beriwal, MB
|
|
Give Review
Sushil Beriwal, MB works in the field of Radiation Oncology. He went to RG Kar Medical College Calcutta. He has 1 awards "Top MD". Sushil Beriwal is a published doctor. He has 102 papers published. The most current publication "In regard to Wu and Vapiwala et al." He accepts all Medicare patients.
Publications
- Reply to A.J. Olszewski et al.
- Anaplastic thyroid Cancer: Prognostic factors, patterns of care, and overall survival.
- Underutilization of radiation therapy in early-stage marginal zone lymphoma negatively impacts overall survival.
- Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective.
- Medicare Approves Coverage for Lung Cancer Screening: The Case for Symptomatic Screening.
- Management Trends and Outcomes for Stage I to II Mantle Cell Lymphoma Using the National Cancer Data Base: Ascertaining the Ideal Treatment Paradigm.
- Clinical Pathways: A Catalyst for the Adoption of Hypofractionation for Early-Stage Breast Cancer.
- Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
- Caveat for Immortal Time Bias in Adjuvant Therapy-Related Population-Based Analyses.
- MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical Cancer: the University of Pittsburgh experience.
- Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation o...
- In regard to dyk et Al.
- Patterns of care for omission of radiation therapy for elderly women with early-stage breast Cancer receiving hormonal therapy.
- No association between left-breast radiation therapy or breast arterial calcification and long-term cardiac events in patients with breast Cancer.
- Image-based brachytherapy for cervical Cancer.
- Primary and Radiation-induced Breast Angiosarcoma: Clinicopathologic Predictors of Outcomes and the Impact of Adjuvant Radiation Therapy.
- In regard to olson et Al and ellsworth et Al.
- Extended field intensity modulated radiation therapy for gynecologic Cancers: Is the risk of duodenal toxicity high?
- Quantitative evaluation of radiation oncologists' adaptability to lower reimbursing treatment programs.
- Patterns of care and brachytherapy boost utilization for vaginal Cancer in the United States.
- Adoption and impact of concurrent chemoradiation therapy for vaginal Cancer: A National Cancer Data Base (NCDB) study.
- Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node-Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patter...
- Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy.
- National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements.
- Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial Cancer clinically extending to the cervix ...
- Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric corr...
- The impact of ionizing radiation on placental trophoblasts.
- Impact of facility volume on therapy and survival for locally advanced cervical Cancer.
- Recommendations for Post-Mastectomy Radiation Therapy after Neo-adjuvant Chemotherapy: An International Survey of Radiation Oncologists.
- Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm Applicable to Other Malignancies-Assessment of Nodal Distribution in Gyn...
- The risk of subsequent malignancies in women with uterine papillary serous or clear cell endometrial Cancers.
- In regard to chakravarti et Al.
- Upfront treatment of locally advanced cervical Cancer with intensity modulated radiation therapy compared to four-field radiation therapy: A cost-effectiveness analysis.
- Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse.
- Predictors of pathologic complete response after standard neoadjuvant chemotherapy in triple-negative breast carcinoma.
- Impact of dynamic changes to a bone metastases pathway in a large, integrated, National Cancer Institute-designated comprehensive Cancer center network.
- Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix Cancer scenarios.
- Changing practice patterns for breast Cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated Cancer center network.
- Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung Cancer treated with stereotactic body radiation therapy.
- Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian Cancer: a feasibility study.
- Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy.
- Comparison between real-time intra-operative ultrasound-based dosimetry and CT-based dosimetry for prostate brachytherapy using cesium-131.
- Recurrent metastatic Vulvar carcinoma treated with cisplatin plus cetuximab.
- Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical Cancer brachytherapy.
- PET/CT-guided radiation therapy planning: from present to the future.
- Evaluation of Set-up Uncertainties with Daily Kilovoltage Image Guidance in External Beam Radiation Therapy for Gynaecological Cancers.
- Three-dimensional high dose rate intracavitary image-guided brachytherapy for the treatment of cervical Cancer using a hybrid magnetic resonance imaging/computed tomog...
- Clinical and dosimetric factors associated with a prolonged feeding tube requirement in patients treated with chemoradiotherapy (CRT) for head and neck Cancers.
- Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for Cancer-related fatigue.
- American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal Cancer.
- American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy.
- American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy.
- Surgery Versus Radiation Therapy for Stage IB2 Cervical Carcinoma: A Population-Based Analysis.
- Intraperitoneal chemotherapy for recurrent epithelial ovarian Cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
- NY-BR-1 and PAX8 Immunoreactivity in Breast, Gynecologic Tract, and Other CK7+ Carcinomas: Potential Use for Determining Site of Origin.
- Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian Cancer: brief rep...
- Molecular class as a predictor of locoregional and distant recurrence in the neoadjuvant setting for breast Cancer.
- Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
- Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast Cancer.
- Cesium 131 versus iodine 125 implants for prostate Cancer: evaluation of early PSA response.
- Predictors of urinary morbidity in Cs-131 prostate brachytherapy implants.
- Acute bowel morbidity after prostate brachytherapy with cesium-131.
- Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels.
- Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131.
- Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical Cancer: is point A-based dose prescription still valid in image-guided ...
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix Cancer.
- Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
- Does the number of nodes removed impact survival in Vulvar cancer patients with node-negative disease?
- Immunohistochemical surrogate markers of breast Cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases.
- Definitive radiation therapy for endometrial Cancer in medically inoperable elderly patients.
- Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate Cancer.
- Completion of intraperitoneal chemotherapy in advanced ovarian Cancer and catheter-related complications.
- Androgen receptor in breast Cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation.
- Breast Cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
- Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
- Initial outcomes analysis for large multicenter integrated Cancer network implementation of intensity modulated radiation therapy for breast Cancer.
- Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast Cancer: a nomogram validation study.
- Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.
- Dosimetric outcomes in prostate brachytherapy: is downsizing the prostate with androgen deprivation necessary?
- Clinical implementation of tangential field intensity modulated radiation therapy (IMRT) using sliding window technique and dosimetric comparison with 3D conformal the...
- The intrafraction motion induced dosimetric impacts in breast 3D radiation treatment: a 4DCT based study.
- Placement technique and the early complications of balloon breast brachytherapy: Magee-Womens Hospital experience.
- Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical Cancer.
- MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
- CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.
- PET-CT in radiation oncology: the impact on diagnosis, treatment planning, and assessment of treatment response.
- Overcoming pubic arch interference with free-hand needle placement in men undergoing prostate brachytherapy.
- Recommendations for permanent prostate brachytherapy with (131)Cs: a consensus report from the Cesium Advisory Group.
- Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance.
- Prostate brachytherapy after ileal pouch-anal anastomosis reconstruction.
- Planning based on postneedle volume with early dosimetric assessment is beneficial for Cesium-131 permanent prostate seed implantation.
- WT1 immunoreactivity in breast carcinoma: selective expression in pure and mixed mucinous subtypes.
- Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced Vulvar carcinoma.
- Factors that predict the burden of axillary disease in breast Cancer patients with a positive sentinel node.
- Histopathologic variables predict Oncotype DX recurrence score.
- High-dose rate brachytherapy (HDRB) for primary or recurrent Cancer in the vagina.
- High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial Cancer: 10-year results.
- Survival for stage IB cervical Cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy.
- Mucosa-associated lymphoid tissue lymphoma of the cervix.
- Breast skin doses from brachytherapy using MammoSite HDR, intensity modulated radiation therapy, and tangential fields techniques.
- In regard to Wu and Vapiwala et al.
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- Top MD
Education
-
Drexel University - Hahnemann University Hospital -
RG Kar Medical College Calcutta
Hospital
-
UPMC Passavant
Drug Facts
| NPI NUMBER | 1538139134 | |
| NPPES Provider LastName | BERIWAL | |
| NPPES Provider FirstName | SUSHIL | |
| NPPES Provider ZIPCode | 152133108 | |
| NPPES Provider State | PA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 148.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 38.0 | |
| Percent Opioid Claims | 25.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538139134 |
| Last Name Of The Provider | BERIWAL |
| First Name Of The Provider | SUSHIL |
| View All |
Similar Doctors
|
|
Dr. Mark G. Trombetta, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jack A. Abarbanel, DO |
|
|
Dr. Robert J. Piroli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel S. Greenberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erik K. Lappinen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Boyer, MD |
|
|
Dr. Serah Choi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn H. Kim, MD |
|
|
Dr. Kimmen Quan, MD |
|
|
Dr. Gaurav Shukla, MD |
|
Dr. Felicia E. Snead, MD
This Doctor is OpenDoctor Recommended.
|